GYRE
GYRE THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.55
+5.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 4.15x
- P/S forward
- 13.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.14x
- Price / sales
- 6.71x
- Price / cash flow
- -55.22x
Enterprise value
- Enterprise value
- $786.2M
- EV / sales
- 6.59x
- EV / EBITDA
- -56.05x
- EV / EBIT
- -47.15x
- Market cap
- $800.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026